Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    Risk Evaluation and Education for Alzheimer's disease REVEAL
Show Display Options
Download search resultsDownload the search results for:
Risk Evaluation and Education for Alzheimer's disease REVEAL (6 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Not yet recruiting Risk Evaluation and Education for Alzheimer's Disease - the Study of Communicating Amyloid Neuroimaging (REVEAL-SCAN)
Conditions: Alzheimer Disease;   Amyloid Beta-Peptides;   Risk Assessment;   Education;   Neuropsychological Tests;   Neuroimaging
Interventions: Behavioral: Alzheimer's Disease Risk Disclosure;   Behavioral: Amyloid Brain Imaging and Alzheimer's Disease Risk Disclosure
2 Unknown  Risk Evaluation and Education for Alzheimer's Disease (REVEAL) IV
Condition: Mild Cognitive Impairment
Interventions: Behavioral: APOE genotype disclosure and Alzheimer's disease risk disclosure;   Behavioral: Alzheimer's disease risk disclosure
3 Completed
Has Results
REVEAL III: Risk Evaluation and Education for Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Behavioral: Pleiotropic info, in-person disclosure;   Behavioral: AD-only info, in-person disclosure;   Behavioral: Pleiotropic info, phone disclosure;   Behavioral: AD-only info, phone disclosure
4 Completed Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II
Condition: Alzheimer Disease
Intervention: Procedure: APOE Genetic susceptibility testing
5 Completed Risk Evaluation and Education for Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Behavioral: APOE Disclosure
6 Not yet recruiting Effect of Elderberry Juice on Cognition and Inflammation in Patients With Mild Cognitive Impairment
Condition: Mild Cognitive Impairment
Interventions: Biological: Elderberry Juice;   Other: Placebo

Study has passed its completion date and status has not been verified in more than two years.